BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 23910615)

  • 1. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
    Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
    J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
    Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
    Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.
    Cavazzana I; Ceribelli A; Quinzanini M; Scarsi M; Airò P; Cattaneo R; Franceschini F
    Lupus; 2008 Aug; 17(8):727-32. PubMed ID: 18625650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
    Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
    Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
    Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
    Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare autoantibodies to cellular antigens in systemic lupus erythematosus.
    Fredi M; Cavazzana I; Quinzanini M; Taraborelli M; Cartella S; Tincani A; Franceschini F
    Lupus; 2014 Jun; 23(7):672-7. PubMed ID: 24557777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic.
    Bernardino V; Rodrigues A; Lladó A; Panarra A
    Rheumatol Int; 2020 Feb; 40(2):295-301. PubMed ID: 31451935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease.
    Rigolet A; Musset L; Dubourg O; Maisonobe T; Grenier P; Charuel JL; Behin A; Herson S; Amoura Z; Benveniste O
    Medicine (Baltimore); 2012 Mar; 91(2):95-102. PubMed ID: 22391471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A juvenile case of overlap syndrome of systemic lupus erythematosus and polymyositis, later accompanied by systemic sclerosis with the development of anti-Scl 70 and anti-Ku antibodies.
    Nitta Y; Muramatsu M
    Pediatr Dermatol; 2000; 17(5):381-3. PubMed ID: 11085667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.
    Markusse IM; Meijs J; de Boer B; Bakker JA; Schippers HPC; Schouffoer AA; Ajmone Marsan N; Kroft LJM; Ninaber MK; Huizinga TWJ; de Vries-Bouwstra JK
    Rheumatology (Oxford); 2017 Jul; 56(7):1081-1088. PubMed ID: 27940596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.
    Hoa S; Hudson M; Troyanov Y; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ;
    Medicine (Baltimore); 2016 Aug; 95(35):e4713. PubMed ID: 27583908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis.
    Lakota K; Thallinger GG; Sodin-Semrl S; Rozman B; Ambrozic A; Tomsic M; Praprotnik S; Cucnik S; Mrak-Poljsak K; Ceribelli A; Cavazzana I; Franceschini F; Vencovsky J; Czirják L; Varjú C; Steiner G; Aringer M; Stamenkovic B; Distler O; Matucci-Cerinic M; Kveder T
    Arthritis Res Ther; 2012 Jan; 14(1):R2. PubMed ID: 22226402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
    Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
    Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and serological hallmarks of systemic sclerosis overlap syndromes.
    Pakozdi A; Nihtyanova S; Moinzadeh P; Ong VH; Black CM; Denton CP
    J Rheumatol; 2011 Nov; 38(11):2406-9. PubMed ID: 21844148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against Ku protein in sera from patients with autoimmune diseases.
    Yaneva M; Arnett FC
    Clin Exp Immunol; 1989 Jun; 76(3):366-72. PubMed ID: 2665976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and serological associations of anti-Ku antibody.
    Cooley HM; Melny BJ; Gleeson R; Greco T; Kay TW
    J Rheumatol; 1999 Mar; 26(3):563-7. PubMed ID: 10090163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.